Clinical trial
Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function
NCT00264693 · Luzerner Kantonsspital, Other · Completed
Key facts
| NCT number | NCT00264693 |
|---|---|
| Title | Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function |
| Official title | Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function |
| Lead sponsor | Luzerner Kantonsspital, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Renal Insufficiency |
| Enrollment | 96 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 13, 2005 |
| Last update posted | Jan 26, 2010 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: